Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Cognition in Parkinson's Disease
NCT01497652Phase 4Completed
- Sponsor
- Georgetown University
- Start
- Jan 2012
- Primary completion
- Mar 2015
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by Georgetown University. Started Jan 2012; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01497652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497652.